7.25
price down icon2.42%   -0.12
after-market Handel nachbörslich: 7.25
loading
Schlusskurs vom Vortag:
$7.37
Offen:
$7.09
24-Stunden-Volumen:
504.91K
Relative Volume:
6.46
Marktkapitalisierung:
$6.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.98%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$7.09
$7.61
1-Wochen-Bereich:
Value
$6.71
$7.6437
52-Wochen-Spanne:
Value
$6.71
$13.47

Jade Biosciences Inc Stock (JBIO) Company Profile

Name
Firmenname
Jade Biosciences Inc
Name
Telefon
617-443-2400
Name
Adresse
930 WINTER STREET, WALTHAM
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-19
Name
Neueste SEC-Einreichungen
Name
JBIO's Discussions on Twitter

Vergleichen Sie JBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JBIO
Jade Biosciences Inc
7.25 248.70M 0 0 0 0.00
Biotechnology icon
ONC
Beigene Ltd Adr
240.45 25.61B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.28 114.83B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 41.82M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.43 66.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.36B 0 -153.72M -103.81M -2.00

Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-07 Eingeleitet Wedbush Outperform
2025-05-05 Eingeleitet Stifel Buy
2025-05-02 Eingeleitet TD Cowen Buy
2024-06-18 Herabstufung Evercore ISI Outperform → In-line
2024-06-18 Herabstufung TD Cowen Buy → Hold
2024-06-18 Herabstufung Wells Fargo Overweight → Equal Weight
2024-06-17 Herabstufung BTIG Research Buy → Neutral
2024-06-17 Herabstufung Guggenheim Buy → Neutral
2024-06-17 Herabstufung Wedbush Outperform → Neutral
2024-03-25 Fortgesetzt Jefferies Buy
2023-12-08 Eingeleitet Wells Fargo Equal Weight
2023-03-01 Eingeleitet Guggenheim Buy
2022-12-06 Hochstufung BTIG Research Neutral → Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-16 Herabstufung BTIG Research Buy → Neutral
2022-02-11 Eingeleitet BTIG Research Buy
2021-07-26 Eingeleitet Cowen Outperform
2021-07-26 Eingeleitet Evercore ISI Outperform
2021-07-26 Eingeleitet Jefferies Buy
2021-07-26 Eingeleitet Wedbush Outperform
Alle ansehen

Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten

pulisher
May 20, 2025

Insider Buying: CEO Tom Frohlich Acquires Shares in Jade Biosciences Inc (JBIO) - GuruFocus

May 20, 2025
pulisher
May 14, 2025

Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences, Inc. Completes Reverse Merger, Launches Nasdaq Trading as JBIO, and Secures $300 Million Financing - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Jade Biosciences Secures Massive $300M Funding After Nasdaq Debut, First Clinical Trial Set for 2025 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 13, 2025
pulisher
May 05, 2025

Stifel Nicolaus Initiates Coverage on Jade Biosciences With Buy Rating, $19 Price Target - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Stifel initiates Jade Biosciences stock with a Buy, $19 target By Investing.com - Investing.com India

May 05, 2025
pulisher
May 05, 2025

Stifel initiates Jade Biosciences stock with a Buy, $19 target - Investing.com

May 05, 2025
pulisher
May 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - marketscreener.com

May 03, 2025
pulisher
May 03, 2025

Aerovate Therapeutics, Inc. Announces Board Changes - marketscreener.com

May 03, 2025
pulisher
May 02, 2025

TD Cowen starts Jade Biosciences coverage with Buy rating By Investing.com - Investing.com Nigeria

May 02, 2025
pulisher
May 02, 2025

TD Cowen Initiates Coverage on Jade Biosciences With Buy Rating - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TD Cowen starts Jade Biosciences coverage with Buy rating - Investing.com

May 02, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Completes Merger with Jade Biosciences - TipRanks

May 01, 2025
pulisher
May 01, 2025

Aerovate Therapeutics Announces Range of Expected Cash Dividend - marketscreener.com

May 01, 2025
pulisher
Apr 30, 2025

RTW Biotech Opportunities’ Jade Biosciences merges with Aerovate Therapeutics - QuotedData

Apr 30, 2025
pulisher
Apr 28, 2025

Jade Biosciences closes merger with Aerovate Therapeutics - Business in Vancouver

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously ... - Bluefield Daily Telegraph

Apr 28, 2025
pulisher
Apr 28, 2025

Jade Biosciences Completes Closing of Merger with Aerovate - GlobeNewswire

Apr 28, 2025
pulisher
Apr 25, 2025

Aerovate Therapeutics, Inc. SEC 10-Q Report - TradingView

Apr 25, 2025
pulisher
Apr 24, 2025

Aerovate (AVTE) Approves 1-for-35 Reverse Stock Split Amid Merge - GuruFocus

Apr 24, 2025
pulisher
Apr 21, 2025

Aerovate Therapeutics stockholders approve proposed merger with Jade Biosciences - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Aerovate approves reverse split ahead of Jade merger - Investing.com

Apr 21, 2025
pulisher
Apr 09, 2025

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - The Malaysian Reserve

Apr 09, 2025
pulisher
Apr 07, 2025

Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire

Apr 07, 2025
pulisher
Mar 27, 2025

Aerovate Therapeutics Inc. (AVTE) reports earnings - qz.com

Mar 27, 2025
pulisher
Mar 21, 2025

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire

Mar 21, 2025
pulisher
Feb 28, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 12, 2025

Jade Biosciences to Participate in TD Cowen’s 45th Annual - GlobeNewswire

Feb 12, 2025
pulisher
Jan 23, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerIPG, VTS, AVTE, MHLD - The Victoria Advocate

Jan 23, 2025
pulisher
Dec 28, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Dec 28, 2024
pulisher
Dec 19, 2024

Borealis Biosciences Appoints Christian Hordo as CEO and Expands Series A Financing - Business Wire

Dec 19, 2024
pulisher
Nov 13, 2024

Jade Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 13, 2024
pulisher
Nov 01, 2024

How Fairmount’s Paragon incubator steered two more companies to NASDAQ - biocentury.com

Nov 01, 2024
pulisher
Oct 31, 2024

Paragon spinout Jade casts reverse merger spell with Aerovate - Fierce Biotech

Oct 31, 2024
pulisher
Oct 29, 2024

Paragon launches another company in hot PD-1xVEGF space that goes straight to reverse merger - Endpoints News

Oct 29, 2024
pulisher
Oct 25, 2024

Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson - Endpoints News

Oct 25, 2024
pulisher
Oct 24, 2024

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million - PR Newswire

Oct 24, 2024
pulisher
Aug 06, 2024

RTW backs Jade Biosciences - QuotedData

Aug 06, 2024
pulisher
Aug 05, 2024

Jade Biosciences - The Pharma Letter

Aug 05, 2024
pulisher
Aug 04, 2024

Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More - MedCity News

Aug 04, 2024
pulisher
Aug 02, 2024

Chutes & Ladders—Takeda taps internal leader as head of US oncology business - Fierce Biotech

Aug 02, 2024
pulisher
Aug 01, 2024

Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases - PR Newswire

Aug 01, 2024
pulisher
Jun 17, 2024

Aerovate scraps late-stage study of lung disorder drug - marketscreener.com

Jun 17, 2024
pulisher
Mar 05, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 05, 2024
pulisher
Jun 29, 2021

AVTEAerovate Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Jun 29, 2021
pulisher
Jun 27, 2021

Jade Biosciences Inc Stock Price Today | NASDAQ: JBIO Live - Investing.com

Jun 27, 2021

Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)

Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price up icon 0.00%
$31.02
price down icon 0.96%
$579.77
price down icon 1.33%
$290.05
price up icon 0.45%
$4.28
price up icon 0.71%
$75.61
price up icon 0.73%
Kapitalisierung:     |  Volumen (24h):